FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

779556000: Product containing only inotuzumab ozogamicin in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3740816017 Product containing only inotuzumab ozogamicin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740817014 Inotuzumab ozogamicin only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740816017 Product containing only inotuzumab ozogamicin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740817014 Inotuzumab ozogamicin only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5566701000241118 produit contenant seulement de l'inotuzumab ozogamicine sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5566701000241118 produit contenant seulement de l'inotuzumab ozogamicine sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Inotuzumab ozogamicin only product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Inotuzumab ozogamicin only product in parenteral dose form Is a Product containing inotuzumab ozogamicin in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Inotuzumab ozogamicin only product in parenteral dose form Count of base of active ingredient un false Inferred relationship Existential restriction modifier (core metadata concept)
Inotuzumab ozogamicin only product in parenteral dose form Is a Product containing only inotuzumab ozogamicin (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Inotuzumab ozogamicin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Inotuzumab ozogamicin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inotuzumab ozogamicin only product in parenteral dose form Plays role Antineoplastic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Is a True Inotuzumab ozogamicin only product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start